Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-09-000353
Filing Date
2009-02-12
Accepted
2009-02-12 14:09:38
Documents
1
Period of Report
2009-02-12

Document Format Files

Seq Description Document Type Size
1 a96380_ex.html 4  
1 a96380_ex.xml 4 3227
  Complete submission text file 0001178913-09-000353.txt   5262
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-4-850-1080
PLURISTEM THERAPEUTICS INC (Issuer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 24 BARKAN STREET RISHON LEZION L3 00000
Business Address 972-48501080
BEN-YORAM ISRAEL (Reporting) CIK: 0001320556 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31392 | Film No.: 09593786